Loading clinical trials...
Loading clinical trials...
Alzheimer's disease (AD) is characterised by a progressive loss of memory and cognitive function. In the early stages of AD, there is a progressive accumulation of molecules: β-amyloid peptides (Aβ) i...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Montpellier
Collaborators
NCT05016700 · Defecation Disorder, Neuropathology, and more
NCT06782074 · Epilepsy, Quality of Life, and more
NCT03826407 · Coma, Disorder of Consciousness, and more
NCT02778321 · Neuropathology
University Hospital, Montpellier
Montpellier
University Hospital of Poitiers
Poitiers
University Hospital of Toulouse
Toulouse
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions